• 2022
  Momboisse F, Nardi G, Colin P, Hery M, Cordeiro N, Blachier S, Schwartz O, Arenzana-Seisdedos F, Sauvonnet N, Olivo-Marin JC, Lagane B, Lagache T, Brelot A, , Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5 dynamics depending on its dimerization status., Elife 2022 Jul; 11(): .
• 2022
  Claireaux M, Robinot R, Kervevan J, Patgaonkar M, Staropoli I, Brelot A, Nouël A, Gellenoncourt S, Tang X, Héry M, Volant S, Perthame E, Avettand-Fenoël V, Buchrieser J, Cokelaer T, Bouchier C, Ma L, Boufassa F, Hendou S, Libri V, Hasan M, Zucman D, de Truchis P, Schwartz O, Lambotte O, Chakrabarti LA, , Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry., Nat Commun 2022 Jan; 13(1): 521.
• 2018
  Colin P, Zhou Z, Staropoli I, Garcia-Perez J, Gasser R, Armani-Tourret M, Benureau Y, Gonzalez N, Jin J, Connell BJ, Raymond S, Delobel P, Izopet J, Lortat-Jacob H, Alcami J, Arenzana-Seisdedos F, Brelot A, Lagane B, CCR5 structural plasticity shapes HIV-1 phenotypic properties, PLoS Pathog. 2018 Dec;14(12):e1007432.
• 2018
  Brelot A, Chakrabarti LA, CCR5 Revisited: How Mechanisms of HIV Entry Govern AIDS Pathogenesis, J. Mol. Biol. 2018 Aug;430(17):2557-2589.
• 2018
  Jin J, Momboisse F, Boncompain G, Koensgen F, Zhou Z, Cordeiro N, Arenzana-Seisdedos F, Perez F, Lagane B, Kellenberger E, Brelot A, CCR5 adopts three homodimeric conformations that control cell surface delivery, Sci Signal 2018 05;11(529).
• 2014
  Jin J, Colin P, Staropoli I, Lima-Fernandes E, Ferret C, Demir A, Rogée S, Hartley O, Randriamampita C, Scott MG, Marullo S, Sauvonnet N, Arenzana-Seisdedos F, Lagane B, Brelot A, Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry, J. Biol. Chem. 2014 Jul;289(27):19042-52.
• 2013
  Colin P, Bénureau Y, Staropoli I, Wang Y, Gonzalez N, Alcami J, Hartley O, Brelot A, Arenzana-Seisdedos F, Lagane B, HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines, Proc. Natl. Acad. Sci. U.S.A. 2013 Jun;110(23):9475-80.
• 2007
  Delhaye M, Gravot A, Ayinde D, Niedergang F, Alizon M, Brelot A, Identification of a postendocytic sorting sequence in CCR5, Mol. Pharmacol. 2007 Dec;72(6):1497-507.
• 2005
  Lemay J, Marullo S, Jockers R, Alizon M, Brelot A, On the dimerization of CCR5, Nat. Immunol. 2005 Jun;6(6):535; author reply 535-6.
• 2004
  Ahr B, Denizot M, Robert-Hebmann V, Brelot A, Biard-Piechaczyk M, Identification of the cytoplasmic domains of CXCR4 involved in Jak2 and STAT3 phosphorylation, J. Biol. Chem. 2005 Feb;280(8):6692-700.
• 2004
  Cao TT, Brelot A, von Zastrow M, The composition of the beta-2 adrenergic receptor oligomer affects its membrane trafficking after ligand-induced endocytosis, Mol. Pharmacol. 2005 Jan;67(1):288-97.
• 2001
  Baribaud F, Edwards TG, Sharron M, Brelot A, Heveker N, Price K, Mortari F, Alizon M, Tsang M, Doms RW, Antigenically distinct conformations of CXCR4, J. Virol. 2001 Oct;75(19):8957-67.
• 2001
  Labrosse B, Treboute C, Brelot A, Alizon M, Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor, J. Virol. 2001 Jun;75(12):5457-64.
• 2001
  Brelot A, Alizon M, HIV-1 entry and how to block it, AIDS 2001;15 Suppl 5:S3-11.
• 2001
  Trouplin V, Salvatori F, Cappello F, Obry V, Brelot A, Heveker N, Alizon M, Scarlatti G, Clavel F, Mammano F, Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay, J. Virol. 2001 Jan;75(1):251-9.
• 2000
  Brelot A, Heveker N, Montes M, Alizon M, Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities, J. Biol. Chem. 2000 Aug;275(31):23736-44.
• 1999
  Brelot A, Heveker N, Adema K, Hosie MJ, Willett B, Alizon M, Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses, J. Virol. 1999 Apr;73(4):2576-86.
• 1998
  Willett BJ, Adema K, Heveker N, Brelot A, Picard L, Alizon M, Turner JD, Hoxie JA, Peiper S, Neil JC, Hosie MJ, The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus, J. Virol. 1998 Aug;72(8):6475-81.
• 1998
  Labrosse B, Brelot A, Heveker N, Sol N, Schols D, De Clercq E, Alizon M, Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100, J. Virol. 1998 Aug;72(8):6381-8.
• 1998
  Reeves JD, Heveker N, Brelot A, Alizon M, Clapham PR, Picard L, The second extracellular loop of CXCR4 is involved in CD4-independent entry of human immunodeficiency virus type 2, J. Gen. Virol. 1998 Jul;79 ( Pt 7):1793-9.
• 1997
  Ugolini S, Moulard M, Mondor I, Barois N, Demandolx D, Hoxie J, Brelot A, Alizon M, Davoust J, Sattentau QJ, HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4, J. Immunol. 1997 Sep;159(6):3000-8.
• 1997
  Pleskoff O, Tréboute C, Brelot A, Heveker N, Seman M, Alizon M, Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry, Science 1997 Jun;276(5320):1874-8.
• 1997
  Brelot A, Heveker N, Pleskoff O, Sol N, Alizon M, Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity, J. Virol. 1997 Jun;71(6):4744-51.